Giuseppe Dastoli

1.2k total citations
23 papers, 806 citations indexed

About

Giuseppe Dastoli is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Giuseppe Dastoli has authored 23 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Giuseppe Dastoli's work include Retinoids in leukemia and cellular processes (9 papers), Estrogen and related hormone effects (6 papers) and CAR-T cell therapy research (4 papers). Giuseppe Dastoli is often cited by papers focused on Retinoids in leukemia and cellular processes (9 papers), Estrogen and related hormone effects (6 papers) and CAR-T cell therapy research (4 papers). Giuseppe Dastoli collaborates with scholars based in Italy, Switzerland and United States. Giuseppe Dastoli's co-authors include P Raffo, Salvatore Toma, L Isnardi, Werner Bollag, Lucia Riccardi, Roberto Giardini, Fabrizio Lombardi, Fernando Ravagnani, Michele Magni and Lorenza Gandola and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Giuseppe Dastoli

23 papers receiving 780 citations

Peers

Giuseppe Dastoli
Laurent Vallat France
Elisa Gruppioni Italy
Laurence Cooke United States
Michael A. Damore United States
Y. Terui Japan
Yasushi Shiratori Japan
S. Sulfaro Italy
I G Schmidt-Wolf Germany
E C Bradley United States
Markus Müschen United States
Laurent Vallat France
Giuseppe Dastoli
Citations per year, relative to Giuseppe Dastoli Giuseppe Dastoli (= 1×) peers Laurent Vallat

Countries citing papers authored by Giuseppe Dastoli

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Dastoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Dastoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Dastoli more than expected).

Fields of papers citing papers by Giuseppe Dastoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Dastoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Dastoli. The network helps show where Giuseppe Dastoli may publish in the future.

Co-authorship network of co-authors of Giuseppe Dastoli

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Dastoli. A scholar is included among the top collaborators of Giuseppe Dastoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Dastoli. Giuseppe Dastoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rotiroti, Maria Caterina, Chiara Buracchi, Silvia Arcangeli, et al.. (2020). Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System. Molecular Therapy. 28(9). 1974–1986. 42 indexed citations
2.
Magnani, Chiara F., Claudia Cappuzzello, Michela Bardini, et al.. (2018). Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia. Human Gene Therapy. 29(5). 602–613. 39 indexed citations
3.
Falanga, Anna, S. Toma, Marina Marchetti, et al.. (2002). Effect of all‐trans‐Retinoic acid on the hypercoagulable state of patients with breast cancer. American Journal of Hematology. 70(1). 9–15. 12 indexed citations
4.
Federico, Massimo, Umberto Vitolo, Carola Boccomini, et al.. (2001). Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma.. PubMed. 86(9). 951–8. 62 indexed citations
5.
Sacchi, Stefano, et al.. (2001). Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab. Critical Reviews in Oncology/Hematology. 37(1). 13–25. 33 indexed citations
6.
Toma, S., P Raffo, Guido Nicolò, et al.. (2000). Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.. International Journal of Oncology. 17(5). 991–1000. 26 indexed citations
7.
8.
Oliveri, Filippo, Teresa Santantonio, G. Bellati, et al.. (1999). Long Term Response to Therapy of Chronic Anti-Hbe–Positive Hepatitis B Is Poor Independent of Type and Schedule of Interferon. The American Journal of Gastroenterology. 94(5). 1366–1372. 52 indexed citations
9.
Toma, Salvatore, L Isnardi, P Raffo, et al.. (1998). RARα antagonist RO 41-5253 inhibits proliferation and induces apoptosis in breast-cancer cell lines. International Journal of Cancer. 78(1). 86–94. 40 indexed citations
10.
Russo, Domenico, I Iacona, Stefano Sacchi, et al.. (1998). Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling. Clinical Drug Investigation. 16(1). 25–33. 2 indexed citations
11.
Palmeri, S., Maria Meli, Marco Danova, et al.. (1998). 5-Fluorouracil plus interferon α-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: A multicentric randomized study. Journal of Cancer Research and Clinical Oncology. 124(3-4). 191–198. 9 indexed citations
12.
Russo, Domenico, Mario Regazzi, Stefano Sacchi, et al.. (1998). All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase. Leukemia. 12(4). 449–454. 16 indexed citations
13.
Toma, Salvatore, L Isnardi, P Raffo, et al.. (1997). Effects of ALL-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: Growth inhibition and apoptosis induction. International Journal of Cancer. 70(5). 619–627. 102 indexed citations
14.
Toma, Salvatore, et al.. (1997). Synergistic effect between doxorubicin and a low dose of all-trans-retinoic acid in MCF-7 breast cancer cell line. Cancer Letters. 116(1). 103–110. 13 indexed citations
15.
Toma, S., P Raffo, L Isnardi, et al.. (1997). Associations of retinoids, tamoxifen and alpha-interferon 2a in human breast cancer. International Journal of Oncology. 10(3). 597–607. 3 indexed citations
16.
Barbera, Cristiana, Pier Luigi Calvo, Alessandra Coscia, et al.. (1994). Precore Mutant Hepatitis B Virus and Outcome of Chronic Infection and Hepatitis in Hepatitis B e Antigen-Positive Children. Pediatric Research. 36(3). 347–350. 18 indexed citations
17.
Negro, Francesco, M. Baldi, Gioacchino Leandro, et al.. (1994). Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2a. Gastroenterology. 107(2). 479–485. 35 indexed citations
18.
Papineschi, Federico, Alessandro Bucalossi, Enrico Capochiani, et al.. (1994). Recombinant α2a interferon and polycythemia vera: Clinical results and biological evaluation by means of Fourier‐transform infrared microspectroscopy. European Journal Of Haematology. 53(4). 213–217. 14 indexed citations
19.
Petrini, Mario, Giuseppe Dastoli, Paola Valentini, et al.. (1992). Synergistic effects of alpha interferon and 1,25 dihydroxyvitamin D3: preliminary evidence suggesting that interferon induces expression of the vitamin receptor.. PubMed. 76(6). 467–71. 10 indexed citations
20.
Petrini, Mario, et al.. (1987). A case of idiopathic myelofibrosis with poorly differentiated circulating blasts. The role of the fixative in the peroxidase reaction.. PubMed. 71(5). 411–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent Vallat Breakdown of academic impact, for papers by Elisa Gruppioni Breakdown of academic impact, for papers by Laurence Cooke Breakdown of academic impact, for papers by Michael A. Damore Breakdown of academic impact, for papers by Y. Terui Breakdown of academic impact, for papers by Yasushi Shiratori Breakdown of academic impact, for papers by S. Sulfaro Breakdown of academic impact, for papers by I G Schmidt-Wolf Breakdown of academic impact, for papers by E C Bradley Breakdown of academic impact, for papers by Markus Müschen
Rankless by CCL
2026